Research
Pathways of vulnerability
I use model systems and human postmortem tissue to probe mechanisms of neurodegeneration, elucidating connections between life-history factors and selective vulnerability.
Genomic therapeutics
Moving my study of selective vulnerability from bench to bedside, I seek to improve detection, risk-stratification, and treatment for neurodegeneration using novel technologies in highly cross-functional settings.
genetics of neurodegeneration
Germline and somatic pathogenic variants contributing to neurodegenerative disease pathogenesis are underidentified in neurology clinics. We combine approaches in molecular biology and neuropathology to close this gap.
Funding
If you are interested in supporting our work, please reach out to Dr. Ehrenberg at ehrenberg@berkeley.edu